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Abstract
Background: In a population-based sample of school-age children, we investigated
factors associated with rhinitis, and differences between allergic and nonallergic
rhinitis. Amongst children with asthma, we explored the association between rhi-
nitis and asthma severity.
Methods: Children participating in a birth cohort study (n = 906) were reviewed
at age 8 years. Asthma was defined as at least two of the following three features:
physician-diagnosed asthma, currently using asthma medication and current
wheeze. We measured lung function (plethysmography and spirometry) and air-
way hyper-reactivity (AHR; methacholine challenge).
Results: In the analysis adjusted for the presence of asthma, children with rhinitis
had significantly higher AHR (P = 0.001). Maternal smoking and absence of breast-
feeding were stronger predictors of nonallergic rhinitis, whereas current wheeze and
eczema were stronger predictors of allergic rhinitis. Amongst asthmatics (n = 159),
when compared to 76 children without rhinitis, those with rhinitis (n = 83) were 2.89-
fold (95% CI 1.41–5.91) more likely to experience frequent attacks of wheezing, 3.44-
fold (1.19–9.94) more likely to experience severe attacks of wheezing limiting speech,
10.14-fold (1.27–81.21) more likely to have frequent visits to their doctor because of
asthma and nine-fold (1.11–72.83) more likely to miss school. Reported use of intra-
nasal corticosteroids resulted in a numerically small, but consistent reduction in risk,
rendering the associations between rhinitis and asthma severity nonsignificant.
Conclusion: We observed differences in risk factors and severity between allergic
and nonallergic rhinitis. In children with asthma, rhinitis had adverse impact on
asthma severity. The use of intranasal corticosteroids resulted in a small, but con-
sistent reduction in the risk.
Although rhinitis is one of the most common chronic dis-
eases in childhood (1, 2), only a minority of symptomatic
children have appropriate diagnosis (3, 4). The burden of the
disease to individual patients and the society is often underes-
timated, and there is a general paucity of data on the risk
factors and phenotypes of rhinitis in childhood (1). Numer-
ous epidemiological studies have demonstrated a link
between rhinitis and asthma (1), with rhinitis often preceding
asthma development (5). There is evidence to suggest that
amongst adult asthmatics, those with comorbid rhinosinusitis
have poorer quality of life (6), and chronic rhinitis may
be an important comorbidity of severe asthma (7). A cross-
sectional study amongst children and adolescents with
moderate/severe asthma treated with inhaled corticosteroids
(ICS) suggested that concurrent allergic rhinitis may be a risk
factor for the use of emergency care services (8). A recent
cross-sectional survey amongst 203 children with asthma has
reported that allergic rhinitis in this patient group is common
and has an adverse impact on asthma control (9). However,
most previous studies on the impact of rhinitis on childhood
asthma severity have been carried out in selected populations
of asthmatics attending secondary/tertiary care specialist
services (8, 9), and the effect at a population level is
unknown.
We aimed to investigate the risk factors for rhinitis in a
population-based sample of school-age children participating
in an unselected birth cohort and whether there are
differences in risk factors between allergic and nonallergic
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rhinitis. Amongst children with asthma, we investigated the
association between rhinitis and asthma severity.
Methods
Study design
Manchester Asthma and Allergy Study is a population-based
birth cohort (10). Subjects were recruited antenatally and fol-
lowed prospectively. The study was approved by the local
research ethics committee. Parents/guardians gave written
informed consent.
Data sources
Clinical follow-up
Participants attended follow-up at age 8 years. Validated
ISAAC questionnaire (11) was interviewer-administered to
collect information on parentally reported symptoms, doctor
diagnoses and environmental exposures. We performed skin
prick tests to common inhalant allergens (mite, cat, dog,
grass and tree pollen [Bayer, Elkhart, USA]).
Medical records data
We extracted all data from electronic and paper-based pri-
mary care medical records, including prescriptions of ICS
and intranasal corticosteroids (INCS) between January 2006
and February 2008 (median age 10 years).
Lung function, airway hyper-reactivity and airway
inflammation
We measured specific airway resistance (sRaw) using plethys-
mography (12). We used spirometry to measure FEV1
(expressed as % predicted) and FVC (13). Airway hyper-
reactivity (AHR) was assessed using methacholine challenge
(five-step protocol with quadrupling doses of methacholine)
(14). We calculated methacholine dose–response slope
(MDRS) to include all evaluable data as a continuous vari-
able (15). Fractional exhaled nitric oxide (FeNO) was mea-
sured as an indicator of airway inflammation (16).
Definition of variables
Atopy
Mean wheal diameter ≥3 mm than the negative control to at
least one allergen.
Current rhinitis
Positive response to the question ‘In the past 12 months, has
your child ever had a problem with sneezing, or a runny
nose, or a blocked nose when he/she did not have a cold or
the flu?’ We designated current rhinitis in the presence of
atopy as allergic rhinitis, whilst nonallergic rhinitis was
defined as current rhinitis in the absence of atopy.
Current wheeze
Positive response to the question ‘Has your child had wheez-
ing or whistling in the chest in the last 12 months?’
Current asthma
At least two of the following three features: (i) current
wheeze, (ii) current use of asthma medication and (iii) physi-
cian-diagnosed asthma ever.
Wheeze phenotypes
Using prospectively collected data, we defined wheeze pheno-
types as no wheezing, transient-early wheezing, intermittent
wheezing, late-onset wheezing and persistent wheezing (17).
Current maternal smoking
Positive response to the question ‘Does the child’s mother
smoke at present?’
Markers of asthma severity
Number of wheeze attacks
Parentally reported number of attacks of wheezing their child
had in the past 12 months. Troublesome asthma was defined
as four or more attacks.
Nocturnal awakenings
Ascertained by the question ‘In the past 12 months, how
often, on average has your child’s sleep been disturbed due
to wheezing?’ We defined troublesome asthma as one or
more nights with disturbed sleep per week.
Wheeze limiting speech
Positive answer to the question ‘In the past 12 months, has
wheezing been severe enough to limit your child’s speech to
only one or two words at a time between breaths?’
Visits to family doctor for wheeze/asthma
Troublesome asthma was defined as four or more visits in
the past 12 months.
School days missed due to wheezing/asthma
Parentally reported number of school days the child missed
in the past 12 months. We defined troublesome asthma as 6
or more days.
Statistical analysis
Univariate and multivariate analyses were carried out using
logistic regression (SPSS 20.0, Chicago, IN, USA). Analysis
was carried out assuming that covariate data were missing
completely at random. The effect size was measured using
odds ratios (OR) and 95% confidence interval (CI). All mod-
els were adjusted for gender.
Results
Participant flow and demographic data
Of 1184 children born into the study, 133 were allocated to
an intervention group and excluded from this analysis (18).
Questionnaire data were available for 906 children, of whom
815 underwent skin testing, 724 lung function testing, 628
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methacholine challenges and 205 FeNO measurements
(Fig. 1). Current rhinitis was present in 260 of 906 (29%)
children, of whom 229 had skin tests data (140 were desig-
nated as having allergic, and 89 as nonallergic rhinitis). Of
the 905 (18%) participants, 159 had asthma; 259 of 815
(31.7%) were atopic. Figure S1 shows the prevalence and
overlap of comorbid current rhinitis, asthma and eczema.
Factors associated with rhinitis
Results of the univariate analysis are shown in Table S1. We
performed multiple logistic regression analysis including all
factors significantly associated with current rhinitis in the
univariate analysis. Wheeze in the first year of life (OR 1.53,
95% CI 1.04–2.24, P = 0.03), current eczema (1.90, 1.24–
2.91, P = 0.003), and sensitization to grass (3.87, 2.26–6.64,
P < 0.001) and cat (2.05, 1.09–3.86, P = 0.03) remained inde-
pendent associates of rhinitis. We then ascertained the differ-
ences in risk factors between allergic and nonallergic rhinitis
(Table 1). Maternal smoking and having never been breast-
fed were significantly stronger predictors of nonallergic rhini-
tis, whereas current wheeze and eczema were significantly
stronger predictors of allergic rhinitis. Using interference with
daily activities as a marker of severity, allergic rhinitis
appeared to be more severe than nonallergic rhinitis
(Table 1). As expected, allergic rhinitis was more likely to
have a seasonal pattern.
Both wheeze and asthma were strongly associated with
rhinitis, but different associations were observed for differ-
ent wheeze phenotypes. We observed strong associations
with persistent and late-onset wheeze, but there was no
association between rhinitis and transient-early wheezing;
these associations appeared stronger for allergic than
nonallergic rhinitis (Table S2).
In the analysis adjusted for the presence of asthma, chil-
dren with rhinitis had significantly higher AHR (MDRS;
mean difference [95% CI], 0.85 [1.34 – ()0.36],
P = 0.001) and FeNO (mean difference [95% CI], 0.37 [0.21–
0.53], P < 0.001); these associations were significantly stron-
ger for allergic than nonallergic rhinitis (Table S3). Amongst
atopic children, there was no difference in FeNO between
those with and without rhinitis (mean difference [95% CI],
0.23 [0.09 to 0.57], P = 0.17). We found no difference in
lung function (sRaw, FEV1 and FEV1/FVC) between chil-
dren with and without rhinitis.
Rhinitis and asthma severity
Amongst 159 children with asthma, 83 had contemporaneous
rhinitis. There was no significant difference in AHR between
children with rhinitis compared to those without; similarly,
we observed no difference in lung function (Table S4). An
apparent difference in FeNO between asthmatic children with
and without rhinitis was no longer significant after adjust-
ment for atopy (P = 0.16).
In contrast, we observed marked differences between asth-
matic children with and without rhinitis in the frequency of
wheeze attacks, wheeze limiting speech, unscheduled visits to
family doctor because of poor asthma control, and missed
school days (Fig. 2). Compared to asthmatic children with-
out rhinitis, those with both asthma and rhinitis were:
• 2.89-fold (95% CI 1.41–5.91) more likely to experience
frequent attacks of wheezing (P < 0.01).
• 3.44-fold (95% CI 1.19–9.94) more likely to experience
severe attacks of wheezing limiting speech (P = 0.02).
• 10.14-fold (95% CI 1.27–81.21) more likely to have fre-
quent unscheduled visits to their doctor because of
asthma (P = 0.03).
1184 children born into the cohort
1051 Observational Cohort
AGE 8
145 no data 906  questionnaire
SPT, n = 815 LFT, n = 784
FEV1, 
n = 693
sRaw,
n = 784
FeNO,
n = 205
Methacholine
n = 628
133 allocated to Intervention Group
Figure 1 Participant flow.
Table 1 Associates of allergic and nonallergic rhinitis
Allergic rhinitis
n (%)
Nonallergic rhinitis
n (%) P-value
Never breastfed 30/130 (23.1) 32/88 (36.4) 0.03
Current maternal
smoking
18/140 (12.9) 23/89 (25.8) 0.01
Wheeze ever 90/140 (64.3) 44/89 (49.4) 0.02
Current wheeze
(age 8 years)
68/140 (48.6) 12/89 (13.5) <0.001
Persistent wheeze 46/140 (32.9) 14/89 (15.7) 0.009
Current eczema
(age 8 years)
70/140 (50.0) 19/86 (22.1) <0.001
Eczema in the
first year
74/125 (59.2) 28/87 (32.2) <0.001
Interference with
daily activities
79/140 (56.4) 35/89 (39.3) 0.01
Spring/summer
pattern
90/140 (64.3) 41/89 (46.1) 0.009
Perennial 27/140 (19.3) 19/89 (21.3) 0.20
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• 9-fold (95% CI 1.11–72.83) more likely to miss school
because of their asthma (P = 0.04).
A trend that failed to reach statistical significance was
observed for nocturnal awakenings (OR 1.81, 95% CI 0.79–
4.12, P = 0.16).
Influence of treatment for rhinitis on the association of
rhinitis with asthma severity
We carried out an exploratory analysis to ascertain whether
treatment for rhinitis modifies the association of rhinitis
with asthma severity, using multivariate analyses adjusted
for the use of rhinitis medication (Table 2). Adjusting the
analysis for parentally reported use of antihistamines did
not remove the impact of rhinitis or modify the magnitude
of the risk associated with any of the markers of asthma
severity. In contrast, reported use of intranasal corticoster-
oids (INCS) resulted in a numerically small, but consistent
reduction in the risk of frequent wheeze attacks, wheeze
limiting speech, frequent GP visits and school days missed,
rendering these associations between rhinitis and asthma
severity nonsignificant. We observed similar reductions in
risks after adjusting the analysis for the use of ICS
(Table 2), whilst adjustment for both INCS and ICS
appeared to further minimize the impact of rhinitis on
asthma severity (Table S5).
Discussion
Key findings
Our population-based study demonstrated that amongst chil-
dren with asthma, the presence of rhinitis has significant
adverse effect on asthma severity. Amongst asthmatic chil-
dren, contemporaneous rhinitis was associated with more fre-
quent wheeze attacks (2.4-fold increase in risk), more severe
attacks of wheezing associated with speech limitations (3.4-
fold increase in risk), more frequent visits to the family doc-
tor (9.5-fold increase in risk) and greater school absenteeism
because of asthma (nine-fold increase in risk). Whereas
adjusting for the use of antihistamines did not change these
associations, adjusting for the use of INCS resulted in small,
but consistent reductions in risk, rendering the associations
between rhinitis and markers of asthma severity nonsignifi-
cant.
We observed differences in the associated risk and severity
between allergic and nonallergic rhinitis. Having never been
breastfed and being exposed to maternal smoking were
stronger associates of nonallergic than allergic rhinitis,
whereas current wheeze and eczema were significantly stron-
ger predictors of allergic rhinitis, suggesting different causal
pathways.
0
10
20
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40
50
>4 wheeze 
attacks
Wheeze 
limiting 
speech
>4 GP visits Missed 
school
No rhinitis
Rhinitis
%
Figure 2 Rhinitis and markers of asthma severity amongst 159
children with asthma.
Table 2 Rhinitis and markers of asthma severity after medication adjustment
No rhinitis
n (%)
Current rhinitis
n (%) OR 95% CI P-value
≥4 wheezing attacks 15/75 (20.0) 34/81 (41.9) 2.89 1.41–5.91 <0.01
Adjusted for antihistamines 2.93 1.42–6.03 <0.01
Adjusted for INCS 2.23 0.78–6.38 0.13
Adjusted for ICS 1.61 0.59–4.37 0.35
Wheeze limiting speech 5/75 (6.7) 16/81 (19.8) 3.44 1.19–9.94 0.02
Adjusted for antihistamines 3.62 1.25–10.51 0.02
Adjusted for INCS 3.19 0.79–12.89 0.10
Adjusted for ICS 2.13 0.64–7.05 0.22
≥4 visits to GP for asthma 1/75 (1.3) 10/83 (12.1) 10.14 1.27–81.21 0.03
Adjusted for antihistamines 10.35 1.28–83.34 0.03
Adjusted for INCS 7.13 0.83–61.17 0.07
Adjusted for ICS 7.68 0.89–6.17 0.06
≥6 school days missed 1/75 (1.3) 9/83 (10.8) 9.00 1.11–72.83 0.04
Adjusted for antihistamines 8.98 1.23–81.00 0.03
Adjusted for INCS 8.16 0.96–69.21 0.054
Adjusted for ICS 8.03 0.93–9.67 0.06
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Limitations
We relied on parental reporting of child’s symptoms and
acknowledge potential limitations of this approach (19). We
collected data on medication prescribed by primary care
physicians; this, however, does not confirm that the treat-
ments were taken by children. We were unable to obtain
data on all outcomes (including answers to all questions,
skin tests, lung function, AHR and FeNO) for all children;
however, we found no significant differences in demo-
graphic characteristics between children with and without
these data, suggesting that it is unlikely that this has influ-
enced the results (not presented, available on request). We
acknowledge that our definition of allergic rhinitis is an epi-
demiological one and that demonstration of the cause/effect
relationship between exposure to sensitizing allergen and
symptom would be preferable; however, such investigations
are beyond the remit of the present study. Finally, although
we carried out the analyses amongst children participating
in a longitudinal birth cohort study, due to cross-sectional
nature of these data, the results should be interpreted with
caution.
One strength of our study is the large sample of children,
representative of and generalizable to the general population,
with an excellent retention and high follow-up rate.
Interpretation
Prevalence, risk factors and characteristics
Our results confirm that rhinitis is common in school-age
children and that it frequently coexists with asthma (20, 21).
There was a strong association between rhinitis with current
and persistent, but not transient-early wheezing, suggesting
that different wheezing phenotypes may arise through differ-
ent mechanisms (19, 22). The results appear intuitively cor-
rect, with maternal smoking and the absence of breastfeeding
being stronger associates of nonallergic, and wheeze and
eczema of allergic rhinitis. These data suggest that there may
be different phenotypes of rhinitis during childhood,
with both shared and unique developmental pathways (23).
Longitudinal studies may help identification of such pheno-
types.
We found that children with allergic rhinitis had more
severe symptoms than those with nonallergic rhinitis. Simi-
larly, a significant (but underestimated) burden of allergic
rhinitis has been reported previously in a large-scale survey
in the USA (24) and amongst children with asthma from
Turkey (25).
Allergic rhinitis has been shown to increase FeNO, sug-
gesting increased lower airway inflammation (26, 27). In con-
trast to these studies, amongst atopic children in our study,
there was no association between FeNO and rhinitis. We
observed no differences in lung function between children
with and without rhinitis. However, in agreement with the
previous study by Koh et al., (28) we demonstrated higher
airway reactivity amongst children with rhinitis, even after
adjusting for the presence of asthma. Similarly, data from
cross-sectional (29) and population-based studies (30, 31) in
adults have suggested a strong association between allergic
rhinitis and lower airway dysfunction.
Rhinitis and asthma severity
In a recent important cross-sectional study amongst children
with asthma recruited from the hospital asthma clinic, the
presence of allergic rhinitis had significant adverse effect on
asthma control, even when asthma was considered ade-
quately controlled (9). We have extended these observations
to the unselected population of children with asthma and to
a number of other important markers of asthma severity
(including frequency and severity of wheeze attacks, unsched-
uled use of medical care and school absenteeism). Of particu-
lar note is our finding that children with asthma and rhinitis
have ninefold increase in the risk of missing school compared
to children with asthma only.
In both ours and the study by de Groot et al. (9), treat-
ment with INCS appeared to modify the association between
rhinitis and asthma severity. The observed reduction in risk
was not due to missing observations. This is consistent with
findings in a retrospective cohort of older children and
adults, which showed that patients who were treated for
allergic rhinitis were significantly less likely to visit emergency
departments or be hospitalized than those who were not
treated (32). However, this study did not differentiate
between antihistamines and INCS. One could argue that
children with asthma and rhinitis who receive appropriate
rhinitis treatment with INCS may also be prescribed better
asthma treatment, such as ICS. However, the apparent effect
of INCS on asthma severity in our study remained mostly
unchanged when we adjusted the analysis for the use of ICS,
suggesting that it is unlikely that the observed reduction in
asthma severity amongst children using INCS is confounded
by better treatment for asthma. These findings suggests (but
do not prove) that amongst children with asthma and rhini-
tis, appropriate treatment of rhinitis with INCS may improve
asthma control. The definitive answer can only be obtained
in appropriately designed randomized controlled trials; how-
ever, there are as yet no such long-term trials in children
(33). A recent 4-week study amongst children with mild/mod-
erate asthma and intermittent allergic rhinitis has shown that
INCS may improve exercise-induced bronchospasm (34). In
contrast, a double-blind randomized crossover trial amongst
adults with asthma and persistent allergic rhinitis did not
demonstrate any steroid-sparing effect of adding INCS to
low-dose ICS on lower airway outcomes (35). Recent meta-
analysis of 18 studies assessing the effect of INCS on asthma
outcomes in patients with AR and comorbid asthma
concluded that INCS may improve some lower airway
outcomes, but that further studies are needed to confirm
the role of INCS sprays as therapy for asthma outcomes
(33).
In conclusion, we observed differences in risk factors and
severity between allergic and nonallergic rhinitis amongst
school-age children. In children with asthma, the presence of
rhinitis had adverse impact on asthma severity. Adjustment
for the use of INCS resulted in a small, but consistent reduc-
tion in the risk.
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